Citations

Mayo Clinic

Clear

1572 citation(s) found for "Wu, Samuel".

Troubleshooting Implantable Cardioverter-Defibrillator Sensing Problems II
Swerdlow, Charles D. , Asirvatham, Samuel J. , Ellenbogen, Kenneth A. , Friedman, Paul A. , Asirvatham, Samuel J , Ellenbogen, Kenneth A

Circulation: Arrhythmia and Electrophysiology | February 17, 2015 | Volume: 8 | Issue: 1 | Pages: 212-220

10.1161/circep.114.002514 | PMID 25691555 Get It

Immunodeficiency and Autoimmune Enterocolopathy Linked to NFAT5 Haploinsufficiency
Boland, Brigid S. , Widjaja, Christella E. , Banno, Asoka, Zhang, Bing , Kim, Stephanie H. , Stoven, Samantha, Jones, Marilyn C. , Su, Hao , Crowe, Sheila E., Bui, Jack D. , Ho, Samuel B. , Okugawa, Yoshinaga , Goel, Ajay , Marietta, Eric, Khosroheidari, Mahdieh, Jepsen, Kristen , Aramburu, J. , López‐Rodríguez, Cristina , Sandborn, William J. , Chang, John T. , Marietta, Eric V., Peterson, Michael Roy , Murray, Joseph A. , Harismendy, Olivier

The Journal of Immunology | February 10, 2015 | Volume: 194 | Issue: 6 | Pages: 2551-2560

10.4049/jimmunol.1401463 | PMID 25667416 Get It

Abstract The link between autoimmune diseases and primary immunodeficiency syndromes has been increasingly appreciated. Immunologic evaluation of a young man with autoimmune enterocolopathy and unexplained infections revealed evidence of immunodeficiency, including IgG subclass deficiency, impaired Ag-induced lymphocyte proliferation, reduced cytokine production by CD8+ T lymphocytes, and decreased numbers of NK cells. Genetic evaluation identified haploinsufficiency of NFAT5, a transcription factor regulating immune cell function and cellular adaptation to hyperosmotic stress, as a possible cause of this syndrome. Inhibition or deletion of NFAT5 in normal human and murine cells recapitulated several of the immune deficits identified in the patient. These results provide evidence of a primary immunodeficiency disorder associated with organ-specific autoimmunity linked to NFAT5 deficiency.
Associations between Environmental Exposures and Incident Colorectal Cancer by ESR2 Protein Expression Level in a Population-Based Cohort of Older Women
Tillmans, Lori S. , Vierkant, Robert A. , Wang, Alice H., Samadder, N. Jewel , Lynch, Charles F. , Anderson, Kristin E. , French, Amy J. , Haile, Robert W. , Harnack, Lisa , Potter, John D. , Smyrk, Thomas C. , Thibodeau, Stephen N. , Limburg, Paul J. , Slager, Susan L. , Cerhan, James R. , Vierkant, Robert A , Haile, Robert W , Potter, John D

Cancer Epidemiology, Biomarkers & Prevention | February 4, 2015 | Volume: 24 | Issue: 4 | Pages: 713-719

10.1158/1055-9965.epi-14-0756 | PMID 25650184 Get It

Abstract Background: Cigarette smoking (smoking), hormone therapy (MHT), and folate intake (folate) are each thought to influence colorectal cancer risk, but the underlying molecular mechanisms remain incompletely defined. Expression of estrogen receptor β (ESR2) has been associated with colorectal cancer stage and survival. Methods: In this prospective cohort study, we examined smoking, MHT, and folate-associated colorectal cancer risks by ESR2 protein expression level among participants in the Iowa Women's Health Study (IWHS). Self-reported exposure variables were assessed at baseline. Archived, paraffin-embedded colorectal cancer tissue specimens were collected and evaluated for ESR2 protein expression by IHC. Multivariate Cox regression models were fit to estimate relative risks (RR) and 95% confidence intervals (CI) for associations between smoking, MHT, or folate and ESR2-defined colorectal cancer subtypes. Results: Informative environmental exposure and protein expression data were available for 491 incident colorectal cancer cases. Positive associations between ESR2-low and -high tumors and several smoking-related variables were noted, most prominently with average number of cigarettes per day (RR, 4.24; 95% CI, 1.81–9.91 for ESR2-low and RR, 2.15; 95% CI, 1.05–4.41 for ESR2-high for ≥40 cigarettes compared with nonsmokers). For MHT, a statistically significant association with ESR2-low tumors was observed with longer duration of exposure (RR, 0.54; 95% CI, 0.26–1.13 for >5 years compared with never use). No associations were found for folate. Conclusions: In this study, smoking and MHT were associated with ESR2 expression patterns. Impact: These data support possible heterogeneous effects from smoking and MHT on ERβ-related pathways of colorectal carcinogenesis in older women. Cancer Epidemiol Biomarkers Prev; 24(4); 713–9. ©2015 AACR.
Association of Hospital Participation in a Surgical Outcomes Monitoring Program With Inpatient Complications and Mortality
Etzioni, David A. , Wasif, Nabil , Dueck, Amylou C. , Hohmann, Samuel F. , Naessens, James M. , Mathur, Amit K. , Habermann, Elizabeth B. , Cima, Robert R. , Dueck, A. C. , Habermann, Elizabeth

JAMA | February 3, 2015 | Volume: 313 | Issue: 5 | Pages: 505

10.1001/jama.2015.90 | PMID 25647206 Get It

Atrioventricular Node Ablation in Langendorff-Perfused Porcine Hearts Using Carbon Ion Particle Therapy
Richter, Daniel , Prokesch, Hannah, Graeff, Christian , Prall, Matthias, Simoniello, Palma , Fournier, Claudia , Bauer, Julia , Kaderka, Robert, Weymann, Alexander , Szabó, Gábor , Sonnenberg, Karin, Constantinescu, A., Johnson, Susan B., Misiri, Juna, Takami, Mitsuru , Miller, Robert C. , Herman, Michael , Asirvatham, Samuel J. , Jäkel, Oliver , Haberer, Thomas, Durante, Marco , Bert, Christoph , Packer, Douglas L. , Lehmann, H. Immo , Constantinescu, Anna M, Herman, Michael G., Brons, Stephan, Debus, Jürgen, Sonnenberg, Karin, Brons, Stephan , Debus, Jürgen , Bert, Christoph , Durante, Marco , Graeff, Christian , Asirvatham, Samuel J

Circulation: Arrhythmia and Electrophysiology | January 22, 2015 | Volume: 8 | Issue: 2 | Pages: 429-438

10.1161/circep.114.002436 | PMID 25609687 Get It

Background— Particle therapy, with heavy ions such as carbon-12 ( 12 C), delivered to arrhythmogenic locations of the heart could be a promising new means for catheter-free ablation. As a first investigation, we tested the feasibility of in vivo atrioventricular node ablation, in Langendorff-perfused porcine hearts, using a scanned 12C beam. Methods and Results— Intact hearts were explanted from 4 (30–40 kg) pigs and were perfused in a Langendorff organ bath. Computed tomgraphic scans (1 mm voxel and slice spacing) were acquired and 12 C ion beam treatment planning (optimal accelerator energies, beam positions, and particle numbers) for atrioventricular node ablation was conducted. Orthogonal x-rays with matching of 4 implanted clips were used for positioning. Ten Gray treatment plans were repeatedly administered, using pencil beam scanning. After delivery, positron emission tomography-computed tomgraphic scans for detection of β + ( 11 C) activity were obtained. A 12 C beam with a full width at half maximum of 10 mm was delivered to the atrioventricular node. Delivery of 130 Gy caused disturbance of atrioventricular conduction with transition into complete heart block after 160 Gy. Positron emission computed tomgraphy demonstrated dose delivery into the intended area. Application did not induce arrhythmias. Macroscopic inspection did not reveal damage to myocardium. Immunostaining revealed strong γH2AX signals in the target region, whereas no γH2AX signals were detected in the unirradiated control heart. Conclusions— This is the first report of the application of a 12 C beam for ablation of cardiac tissue to treat arrhythmias. Catheter-free ablation using 12C beams is feasible and merits exploration in intact animal studies as an energy source for arrhythmia elimination.
Electrophysiologic Characteristics of Ventricular Arrhythmias Arising From the Aortic Mitral Continuity – Potential Role of the Conduction System
Asirvatham, Samuel J. , authors, on behalf of the, authors, on behalf of the, Asirvatham, Samuel J

Journal of Cardiovascular Electrophysiology | January 15, 2015 | Volume: 26 | Issue: 4 | Pages: No page available

10.1111/jce.12614 | PMID 25588295 Get It

Association of the Colorectal CpG Island Methylator Phenotype with Molecular Features, Risk Factors, and Family History
Weisenberger, Daniel J. , Levine, A. Joan, Long, Tiffany I. , Buchanan, Daniel D. , Walters, Rhiannon, Rosty, Christophe , Joshi, Amit D. , Lindor, Noralane M. , Daftary, Darshana, Gallinger, Steven , Selander, Teresa, Bapat, Bharati , Ahnen, Dennis J. , Haile, Robert W. , Young, Joanne , Haile, Robert W. , Clendenning, Mark , Stern, Mariana Carla , Marchand, Loı̈c Le , Newcomb, Polly A. , Campbell, Peter T. , Casey, Graham , Baron, John A. , Hopper, John L. , Laird, Peter W. , Siegmund, Kimberly D. , Buchanan, Daniel D , Haile, Robert W , Rosty, Christophe

Cancer Epidemiology, Biomarkers & Prevention | January 13, 2015 | Volume: 24 | Issue: 3 | Pages: 512-519

10.1158/1055-9965.epi-14-1161 | PMID 25587051 Get It

Abstract Background: The CpG island methylator phenotype (CIMP) represents a subset of colorectal cancers characterized by widespread aberrant DNA hypermethylation at select CpG islands. The risk factors and environmental exposures contributing to etiologic heterogeneity between CIMP and non-CIMP tumors are not known. Methods: We measured the CIMP status of 3,119 primary population-based colorectal cancer tumors from the multinational Colon Cancer Family Registry. Etiologic heterogeneity was assessed by a case–case study comparing risk factor frequency of colorectal cancer cases with CIMP and non-CIMP tumors using logistic regression to estimate the case–case odds ratio (ccOR). Results: We found associations between tumor CIMP status and MSI-H (ccOR = 7.6), BRAF V600E mutation (ccOR = 59.8), proximal tumor site (ccOR = 9; all P < 0.0001), female sex [ccOR = 1.8; 95% confidence interval (CI), 1.5–2.1], older age (ccOR = 4.0 comparing over 70 years vs. under 50; 95% CI, 3.0–5.5), and family history of CRC (ccOR = 0.6; 95% CI, 0.5–0.7). While use of NSAIDs varied by tumor CIMP status for both males and females (P = 0.0001 and P = 0.02, respectively), use of multivitamin or calcium supplements did not. Only for female colorectal cancer was CIMP status associated with increased pack-years of smoking (Ptrend < 0.001) and body mass index (BMI; Ptrend = 0.03). Conclusions: The frequency of several colorectal cancer risk factors varied by CIMP status, and the associations of smoking and obesity with tumor subtype were evident only for females. Impact: Differences in the associations of a unique DNA methylation–based subgroup of colorectal cancer with important lifestyle and environmental exposures increase understanding of the molecular pathologic epidemiology of this heavily methylated subset of colorectal cancer. Cancer Epidemiol Biomarkers Prev; 24(3); 512–9. ©2015 AACR.
Pericardial Effusion Following Drain Removal after Percutaneous Epicardial Access for an Electrophysiology Procedure
Killu, Ammar M. , Wan, Siu‐Hin , Munger, Thomas M. , Hodge, David O. , Mulpuru, Siva K. , Packer, Douglas L. , Asirvatham, Samuel J. , Friedman, Paul A. , Asirvatham, Samuel J

Pacing and Clinical Electrophysiology | January 13, 2015 | Volume: 38 | Issue: 3 | Pages: 383-390

10.1111/pace.12565 | PMID 25583074 Get It

ObjectivesTo determine the frequency and predictors of pericardial effusion following epicardial sheath removal.BackgroundPericardial effusion can occur following cardiac surgical or interventional procedures including percutaneous epicardial access (EpiAcc), which is increasingly used as part of electrophysiology ablation procedures.MethodsA retrospective analysis of the Mayo Clinic comprehensive electronic medical record was performed from all patients who underwent planned EpiAcc as part of an electrophysiology ablation procedure between January 1, 2004 and June 30, 2013.ResultsOf 144 patients (mean age 51.3 ± 15.5 years, 68% male) who underwent planned EpiAcc as part of an electrophysiology ablation (95.8% pericardial access success rate), seven (4.9%) developed a postoperative pericardial effusion requiring repeat EpiAcc. Inferior access was utilized in 74 (51.4%) patients. Patients with pericardial effusion tended to be younger (41.1 years vs 51.8 years, P = 0.08) and were more likely to have undergone inferior approach access (85.7% vs 49.6%, P = 0.06) than those who did not develop postoperative pericardial effusion. Seventy‐one percent of patients with postoperative pericardial effusion versus 32.1% of patients without postoperative pericardial effusion had a preprocedure ejection fraction ≥55% (P = 0.03). There were no procedural‐related deaths, and no difference in mortality between groups.ConclusionsPostoperative pericardial effusion requiring repeat access/drainage was relatively infrequent, occurring in 4.9% of patients shortly after epicardial procedures. While the majority occur early and therefore require close observation, some patients may present in a delayed manner.